Interpretation of Chinese Society of Endocrinology consensus statement on hyperglycemia management target in adult inpatients in China

Journal of Diabetes

Volumn 5, Issue 4, 2013, Pages 416-420

  Lü, Qing guo ^a   Tong, Nan wei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Consensus statement; Hyperglycemia; Inpatients

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C;

BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHINA; CONSENSUS; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION PREVENTION; INSULIN TREATMENT; INTENSIVE CARE; MEDICAL SOCIETY; MORTALITY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORGAN TRANSPLANTATION; PERSONALIZED MEDICINE; POSTOPERATIVE INFECTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WEIGHT GAIN; WOUND HEALING IMPAIRMENT;

CONSENSUS STATEMENT; HYPERGLYCEMIA; INPATIENTS;

ADULT; CHINA; CONSENSUS; ENDOCRINOLOGY; HEALTH PLAN IMPLEMENTATION; HUMANS; HYPERGLYCEMIA; INPATIENTS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84887019224     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12058     Document Type: Review

References (23)

1. International Diabetes Federation. IDF Diabetes Atlas, 5th edn. International Diabetes Federation, Brussels, 2011.
2. Yang W, Lu J, Weng J etal. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090-1101.
3. Cao MM, Tong NW. Stratifying and tailoring HbA1c control targets for adults with Type 2 diabetes: Interpretation of the consensus proposed by the Chinese Society of Endocrinology. J Diabetes. 2011; 3: 201-207.
4. Swanson CM, Potter DJ, Kongable GL, Cook CB. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract. 2011; 17: 853-861.
5. Hu Y, Liu W, Chen Y etal. Clinical analysis of inpatients with hyperglycemia in the medical intensive care units - data of Shanghai Renji Hospital from 2002 to 2009. Chin J Endocrinol Metabol. 2010; 26: 448-451.
6. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control. Diabetes Care. 2006; 29: 1955-1962.
7. Van den Berghe G, Wouters P, Weekers F etal. Intensive insulin therapy in critically ill Patients. N Engl J Med. 2001; 345: 1359-1367.
8. Van den Berghe G, Wilmer A, Hermans G etal. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354: 449-461.
9. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY etal. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360: 1283-1297.
10. Moghissi ES, Korytkowski MT, DiNardo M etal. AACE and ADA consensus statement on inpatient glycemic control. Endocr Pract. 2009; 15: 1-17.
11. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P, Clinical Guidelines Committee of the American College of Physicians. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011; 154: 260-267.
12. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. 2008; 359: 1577-1589.
13. Murad MH, Coburn JA, Yglesias FC etal. Glycemic control in non-critically ill hospitalized patients: A systematic review and meta-analysis. J Clin Endocrinol Metab. 2012; 97: 49-58.
14. Ray KK, Seshasai SRK, Wijesuriya S etal. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. Lancet. 2009; 373: 1765-1772.
15. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J etal. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358: 2560-2572.
16. ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR etal. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012; 367: 319-328.
17. ACCORD Study Group, Cushman WC, Evans GW, Byington RP etal. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362: 1575-1585.
18. Griesdale DEG, de Souza RJ, van Dam RB etal. Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. Can Med Associa J. 2009; 180: 821-827.
19. National Institute of Health and Clinical Excellence. Management of adults with diabetes undergoing surgery and elective procedures: Improving standards. 2011. Available from: http://www.nice.org.uk/
20. Pichardo-Lowden A, Gabbay RA. Management of hyperglycemia during the perioperative period. Current Diab Rep. 2012; 12: 108-118.
21. Kitzmiller JL, Block JM, Brown FM etal. Managing preexisting diabetes for pregnancy summary of evidence and consensus recommendations for care. Diabetes Care. 2008; 31: 1060-1079.
22. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013; 36 (Suppl 1): S11-66.
23. Shi H, Li Y, Liu S, Liang Y, Xiao H. Comparison of efficacies of four different intensive insulin therapies with regard to blood-glucose control and vascular endothelial function in patients with newly-diagnosed type 2 diabetes. Chin J Endocrinol Metabol. 2012; 28: 496-498.